Ramont L - Search Results

1

F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction.

Oudart JB, Villemin M, Brassart B, Sellier C, Terryn C, Dupont-Deshorgue A, Monboisse JC, Maquart FX, Ramont L, Brassart-Pasco S. Oudart JB, et al. Among authors: ramont l. Cell Adh Migr. 2021 Dec;15(1):215-223. doi: 10.1080/19336918.2021.1951425. Cell Adh Migr. 2021. PMID: 34308743 Free PMC article.

2

Implication of interleukin-4 in wound healing.

Salmon-Ehr V, Ramont L, Godeau G, Birembaut P, Guenounou M, Bernard P, Maquart FX. Salmon-Ehr V, et al. Among authors: ramont l. Lab Invest. 2000 Aug;80(8):1337-43. doi: 10.1038/labinvest.3780141. Lab Invest. 2000. PMID: 10950124 Free article.

3

[Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].

Ramont L, Ngoc PT, Pignon B, Maquart FX. Ramont L, et al. Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):565-70. Ann Biol Clin (Paris). 2002. PMID: 12368142 Free article. French.

4

[Biological effects of collagen I and IV peptides].

Pasco S, Ramont L, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. J Soc Biol. 2003;197(1):31-9. J Soc Biol. 2003. PMID: 12868264 Review. French.

5

The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent.

Floquet N, Pasco S, Ramont L, Derreumaux P, Laronze JY, Nuzillard JM, Maquart FX, Alix AJ, Monboisse JC. Floquet N, et al. Among authors: ramont l. J Biol Chem. 2004 Jan 16;279(3):2091-100. doi: 10.1074/jbc.M307736200. Epub 2003 Oct 28. J Biol Chem. 2004. PMID: 14583633 Free article.

6

Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.

Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC. Ramont L, et al. Exp Cell Res. 2003 Nov 15;291(1):1-10. doi: 10.1016/s0014-4827(03)00336-7. Exp Cell Res. 2003. PMID: 14597403

7

An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion.

Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC. Maquart FX, et al. Among authors: ramont l. Crit Rev Oncol Hematol. 2004 Mar;49(3):199-202. doi: 10.1016/j.critrevonc.2003.06.007. Crit Rev Oncol Hematol. 2004. PMID: 15036260 Review.

8

Control of melanoma progression by various matrikines from basement membrane macromolecules.

Pasco S, Ramont L, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. Crit Rev Oncol Hematol. 2004 Mar;49(3):221-33. doi: 10.1016/j.critrevonc.2003.09.006. Crit Rev Oncol Hematol. 2004. PMID: 15036262 Review.

9

The small leucine-rich proteoglycan lumican inhibits melanoma progression.

Vuillermoz B, Khoruzhenko A, D'Onofrio MF, Ramont L, Venteo L, Perreau C, Antonicelli F, Maquart FX, Wegrowski Y. Vuillermoz B, et al. Among authors: ramont l. Exp Cell Res. 2004 Jun 10;296(2):294-306. doi: 10.1016/j.yexcr.2004.02.005. Exp Cell Res. 2004. PMID: 15149859

10

In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.

Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. Exp Cell Res. 2004 Dec 10;301(2):251-65. doi: 10.1016/j.yexcr.2004.07.036. Exp Cell Res. 2004. PMID: 15530861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page